Search
                    Cisplatin Treatment Options in Orlando, FL
A collection of 123 research studies where Cisplatin is the interventional treatment. These studies are located in the Orlando, FL. Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-Small Cell Lung Cancer.
            109 - 120 of 123
        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if gemcitabine is more effective when given alone or in combination with another chemotherapy drug in treating cancer of the pancreas.
PURPOSE: Randomized phase II trial to compare the effectiveness of gemcitabine given alone or in combination with other chemotherapy drugs in treating patients who have metastatic cancer of the pancreas.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/12/2016
            
            Locations: Broward General Medical Center, Fort Lauderdale, Florida  +4 locations         
        
        
            Conditions: Pancreatic Cancer
        
            
        
    
                
                                    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
                                
            
            
        Completed
                            
            
                This trial is designed to test the efficacy of fluoxetine to improve patient's quality of life during chemotherapy. An innovative application of a selective serotonin reuptake inhibitor may modulate the effects of fatigue, anxiety and depression which worsen quality of life.             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                07/01/2016
            
            Locations: Broward General Medical Center, Fort Lauderdale, Florida  +3 locations         
        
        
            
        
    
                
                                    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
                                
            
            
        Terminated
                            
            
                RATIONALE: Drugs used in chemotherapy, such as ifosfamide, cisplatin, paclitaxel, and vinblastine, work in different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether ifosfamide and cisplatin are more effective when combined with paclitaxel or vinblastine in treating germ cell tumors.
PURPOSE: This randomized phase III trial is studying paclitaxel, ifosfamide, and cisplatin to see how well they work compared to vinblastine, ifosfamide, and cisplatin...  Read More             
        
        
    Gender:
                MALE
            Ages:
                Between 18 years and 120 years
            Trial Updated:
                07/01/2016
            
            Locations: Broward General Medical Center, Fort Lauderdale, Florida  +4 locations         
        
        
            Conditions: Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
        
            
        
    
                
                                    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. Radiation therapy uses high-energy x-rays to damage tumor cells.
PURPOSE: Phase II trial to study the effectiveness of paclitaxel, cisplatin, and filgrastim combined w...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                11/14/2015
            
            Locations: University of Florida Health Science Center, Gainesville, Florida  +12 locations         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy following surgery may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy plus radiation therapy in treating patients who have undergone surgery for stage III or stage IV head and neck cancer.             
        
        
    Gender:
                ALL
            Ages:
                21 years and above
            Trial Updated:
                11/14/2015
            
            Locations: University of Florida Health Science Center, Gainesville, Florida  +12 locations         
        
        
            Conditions: Head and Neck Cancer
        
            
        
    
                
                                    S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy, such as cisplatin, etoposide, gemcitabine, and methylprednisolone, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.
PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating patients with newly diagnosed stage II, stage III, or stage IV T-cell non-Hodgkin's lymphoma.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/18/2014
            
            Locations: M.D. Anderson Cancer Center at Orlando, Orlando, Florida         
        
        
            Conditions: Lymphoma
        
            
        
    
                
                                    Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Chemoprotective drugs such as dexrazoxane may protect normal cells from the side effects of chemotherapy.
PURPOSE: Phase III trial to study the effectiveness of three combination chemotherapy regimens plus dexrazoxane in treating patients who have newly diagnosed nonmetastatic osteosarcoma.             
        
        
    Gender:
                ALL
            Ages:
                30 years and below
            Trial Updated:
                08/04/2014
            
            Locations: Shands Hospital and Clinics, University of Florida, Gainesville, Florida  +8 locations         
        
        
            Conditions: Cardiac Toxicity, Sarcoma
        
            
        
    
                
                                    Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of etoposide plus radiation therapy followed by combination chemotherapy in treating children with newly diagnosed advanced medulloblastoma.             
        
        
    Gender:
                ALL
            Ages:
                Between 3 years and 21 years
            Trial Updated:
                07/24/2014
            
            Locations: Shands Hospital and Clinics, University of Florida, Gainesville, Florida  +6 locations         
        
        
            Conditions: Brain Tumors, Central Nervous System Tumors
        
            
        
    
                
                                    Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
PURPOSE: This clinical trial is studying the side effects and best dose of zoledronic acid when given together with combination chemotherapy in treating patients with newly diagnosed metastatic osteosarcoma.             
        
        
    Gender:
                ALL
            Ages:
                40 years and below
            Trial Updated:
                06/04/2014
            
            Locations: Nemours Children's Clinic, Jacksonville, Florida  +5 locations         
        
        
            Conditions: Sarcoma
        
            
        
    
                
                                    A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
                                
            
            
        Completed
                            
            
                The purpose of this study is to look for an improvement in progression free survival with the combination of pemetrexed, carboplatin (or cisplatin) and cetuximab in participants with recurrent or metastatic squamous cell carcinoma of the head and neck.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                04/18/2014
            
            Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fort Myers, Florida  +1 locations         
        
        
            Conditions: Head and Neck Neoplasms
        
            
        
    
                
                                    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
                                
            
            
        Completed
                            
            
                RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining more than one chemotherapy drug with radiation therapy may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus combination chemotherapy in treating patients with limited-stage small cell lung cancer.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                10/31/2013
            
            Locations: Lykes Center for Radiation Therapy, Clearwater, Florida  +15 locations         
        
        
            Conditions: Lung Cancer
        
            
        
    
                
                                    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
                                
            
            
        Completed
                            
            
                RATIONALE: Chemotherapy drugs use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy.
PURPOSE: Phase I trial to study the effectiveness of high-dose cisplatin, etoposide, and bleomycin plus amifostine in treating children who have malignant germ cell tumors.             
        
        
    Gender:
                ALL
            Ages:
                14 years and below
            Trial Updated:
                07/03/2013
            
            Locations: Shands Hospital and Clinics, University of Florida, Gainesville, Florida  +7 locations         
        
        
            Conditions: Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
        
            
        
    109 - 120 of 123
            